Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity

Lancet Healthy Longev. 2022 Jan;3(1):e2-e3. doi: 10.1016/S2666-7568(21)00304-4. Epub 2021 Dec 16.

Authors

Chris P Verschoor^{1

2}, Dawn M E Bowdish³

Affiliations

¹ Health Sciences North Research Institute, Sudbury, ON, Canada P3E 5J1.
² Northern Ontario School of Medicine, Sudbury, ON, Canada.
³ Department of Pathology and Molecular Medicine, McMaster University, ON, Canada.

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Viral / immunology
COVID-19* / epidemiology
Humans
Long-Term Care
Nucleocapsid
Pandemics
Prevalence
Prospective Studies
SARS-CoV-2*
Seroepidemiologic Studies

Substances

Antibodies, Viral